D. E. Shaw & Co., Inc. Ab Cellera Biologics Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 420,240 shares of ABCL stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

420,240

Holding current value

$1.23 Million

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.39 - $3.49 $110,716 - $161,674	-46,325 Reduced 9.93%	420,240 $1.09 Million
Q2 2024 Aug 14, 2024	BUY	$2.73 - $4.73 $36,390 - $63,050	13,330 Added 2.94%	466,565 $1.38 Million
Q1 2024 May 15, 2024	BUY	$4.29 - $5.97 $1.81 Million - $2.52 Million	422,602 Added 1379.56%	453,235 $2.05 Million
Q4 2023 Feb 14, 2024	SELL	$3.91 - $5.93 $1.58 Million - $2.4 Million	-404,720 Reduced 92.96%	30,633 $174,000
Q3 2023 Nov 14, 2023	SELL	$4.6 - $7.95 $356,270 - $615,727	-77,450 Reduced 15.1%	435,353 $2 Million
Q2 2023 Aug 14, 2023	SELL	$5.66 - $7.59 $5.41 Million - $7.25 Million	-955,593 Reduced 65.08%	512,803 $3.31 Million
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $7.16 Million - $10.9 Million	-979,008 Reduced 40.0%	1,468,396 $11.1 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $3.11 Million - $4.76 Million	-327,955 Reduced 11.82%	2,447,404 $24.8 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $15.4 Million - $22.9 Million	1,672,839 Added 151.73%	2,775,359 $27.4 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $6.14 Million - $11.4 Million	1,073,423 Added 3689.12%	1,102,520 $11.7 Million
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $276,124 - $523,377	-37,014 Reduced 55.99%	29,097 $284,000
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $525,029 - $716,611	40,418 Added 157.31%	66,111 $945,000
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $381,541 - $548,288	25,693 New	25,693 $515,000

Others Institutions Holding ABCL

# of Institutions

154

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $833M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account